Department of Otolaryngology-Head and Neck Surgery, Schulich School of Medicine and Dentistry, Western University, London, Canada.
Department of Otolaryngology-Head and Neck Surgery, Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA.
Cochlear Implants Int. 2022 Sep;23(5):291-299. doi: 10.1080/14670100.2022.2045073. Epub 2022 May 16.
The BONEBRIDGE is a partially implantable, transcutaneous bone conduction device that can be used to treat conductive or mixed mild-to-moderate hearing loss in patients who do not attain sufficient improvement from conventional hearing aids. The following case report describes sequential bilateral BONEBRIDGE implantation in a 25-year-old patient with achondroplasia and bilateral mixed-hearing loss with a significant sensorineural component in the setting of chronic suppurative otitis media. Although the patient did not meet the approved BONEBRIDGE criteria, implantation was successful with improvements in audiological outcomes and self-reported quality of life. There were no reported complications at 5-years post-implantation.
骨桥是一种部分可植入的经皮骨导装置，可用于治疗传导性或混合性轻度至中度听力损失患者，这些患者使用传统助听器无法获得足够的改善。以下病例报告描述了一名 25 岁患有软骨发育不全症和双侧混合性听力损失（伴有慢性化脓性中耳炎的显著感音神经性成分）患者的双侧骨桥序贯植入。尽管该患者不符合骨桥批准的标准，但植入成功，听力结果和自我报告的生活质量均得到改善。植入后 5 年无报告并发症。
